Provided by Tiger Trade Technology Pte. Ltd.

Oric Pharmaceuticals Inc.

11.99
-0.0400-0.33%
Post-market: 11.990.00000.00%19:30 EDT
Volume:1.09M
Turnover:13.12M
Market Cap:1.24B
PE:-8.87
High:12.29
Open:11.98
Low:11.90
Close:12.03
52wk High:14.68
52wk Low:7.23
Shares:103.52M
Float Shares:88.69M
Volume Ratio:0.66
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3513
EPS(LYR):-1.4747
ROE:-39.80%
ROA:-25.97%
PB:3.26
PE(LYR):-8.13

Loading ...

What ORIC Pharmaceuticals (ORIC)'s Cancer Research UK Partnership Means For Shareholders

Simply Wall St.
·
Oct 08

ORIC Pharmaceuticals (ORIC) Gains A De Risked Path As Undervalued Case Holds

Simply Wall St.
·
Oct 07

Oric Pharmaceuticals participates in a conference call with JPMorgan

TIPRANKS
·
Oct 06

Oric Pharmaceuticals, - Retains Option to Reacquire Oric-259 Rights After Phase 1/2 Data

THOMSON REUTERS
·
Oct 06

Oric® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class Cip2a-Targeted Therapy into Clinical Development

THOMSON REUTERS
·
Oct 06

ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development

GlobeNewswire
·
Oct 06

Leerink Partners Initiates ORIC Pharmaceuticals at Outperform With $26 Price Target

MT Newswires Live
·
Oct 05

Oric Pharmaceuticals, Inc. : Leerink Partners Initiates Coverage with Outperform Rating; Target Price $26

THOMSON REUTERS
·
Oct 05

Oric Pharma Director Richard A. Heyman Disposes of Common Shares Worth $86,518.47

Reuters
·
Oct 03

Oric Pharma Grants 161,550 Inducement Stock Options to New Hires Under 2022 Plan

Reuters
·
Oct 03

Oric Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Oct 03

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Oct 03

Oric Pharma CFO Dominic Piscitelli Disposes of 13,400 Common Shares Worth $181,257.78

Reuters
·
Sep 30

BTIG Initiates ORIC Pharmaceuticals at Buy With $26 Price Target

MT Newswires Live
·
Sep 23

Oric Pharma Grants 39,200 Stock Options, 6,400 RSUs to New Employees Under Inducement Plan

Reuters
·
Sep 05

Oric Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 05

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 05

Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial

TIPRANKS
·
Sep 04

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 03

Oric Pharma CFO Dominic Piscitelli Disposes of 77,000 Common Shares Worth $1.05 Million

Reuters
·
Aug 29